To confirm mTOR pathway activation in MDS iPSC-derived neurons, we performed western blot analysis using antibodies against phosphorylated mTOR (p-mTOR, Ser2448) and phosphorylated S6 (p-S6, Ser235/236). Here, RPS6 is linked to myelodysplastic syndrome.